← Open Payments lookup

DHRUVI PATEL: Open Payments

NPI 1750025276 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,266 in 121 payments from 16 companies in 2025. Trend: 2023 $1,012 · 2024 $1,434 · 2025 $2,266

Food & beverage: $2,266
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc17$357
ABBVIE INC.21$284
Axsome Therapeutics, Inc.15$258
Neurocrine BioSciences, Inc.4$208
Vanda Pharmaceuticals Inc.16$203
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$200
Otsuka America Pharmaceutical, Inc.12$197
E.R. Squibb & Sons, L.L.C.7$159
Takeda Pharmaceuticals U.S.A., Inc.6$96
Bausch Health US, LLC5$95

Products named: SPRAVATO, VRAYLAR, REXULTI, Auvelity, INGREZZA, CAPLYTA, COBENFY, FANAPT.

Industry payments across NC — which companies pay providers there.